Transcript Slides
Vaccine in National Immunization Programme Update June 2016 Countries with Hib vaccine in the national immunization programme; and planned introductions in 2016 Introduced* to date * Includes partial introduction (191 countries or 98%) Not WHO Member States or Not Introduced (3 countries or 2%) Not applicable Data source: WHO/IVB Database, as of 27 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Countries using IPV vaccine to date This information is available from the website @: IPV Introduction, OPV Withdrawal and Routine Immunization Strengthening: http://www.who.int/immunization/diseases/poliomyelitis/in activated_polio_vaccine/en/ (click on the hyperlink to access the website – on its right hand column a slide set presentation in downloadable) Countries with Pneumococcal Conjugate vaccine in the national immunization programme; and planned introductions in 2016 Introduced* to date Planned introductions in 2016 * Includes partial introduction (130 countries or 67%) (6 countries or 3.1%) Not WHO Member States or Not Introduced/No Plans (58 countries or 29.9%) Not applicable Data source: WHO/IVB Database, as of 27 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Countries with Rotavirus vaccine in the national immunization programme; and planned introductions in 2016 Introduced* to date Planned introductions in 2016 * Includes partial introduction (86 countries or 44.3%) (5 countries or 2.6%) Not WHO Member States or Not Introduced/No Plans (103 countries or 53.1%) Not applicable Data source: WHO/IVB Database, as of 27 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Countries with HPV vaccine in the national immunization programme * Includes partial introduction Introduced* to date (67 countries or 34.5%) Not WHO Member State or Not Introduced/No Plans (127 countries or 65.5%) Not applicable Data source: WHO/IVB Database, as of 27 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Countries using Measles Second Dose vaccine to date; and planned introductions in 2016 Introduced to date Planned introductions in 2016 (161 countries or 83%) (2 countries or 1%) Not WHO Member State or Not Introduced/No Plans (31 countries or 16%) Not applicable Data source: WHO/IVB Database, as of 27 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Countries with Rubella vaccine in the national immunization programme; and planned introductions in 2016-2017 Introduced to date Planned introductions in 2016 (149 countries or 76.8%) (10 countries or 5.2%) Not WHO Member State or Not Introduced/No Plans (35 countries or 18%) Not applicable Data source: WHO/IVB Database, as of 27 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Countries with Hepatitis B Birth dose (HepB-BD) vaccine in the national immunization programme 0 8501,700 3,400 Kilometers HepB-BD introduced to date (96 countries or 49%) HepB-BD only for infants born to HBsAG-positive mothers (22 countries or 11%) (72 countries or 37%) HepB in schedule but no HepB-BD Data source: WHO/IVB Databse as at 30 June 2016 and ECDC published data at http://vaccineschedule.ecdc.europa.eu/Pages/Scheduler.aspx 194 WHO Member States Map production Immunization Vaccines and Biologicals (IVB), World Health Organization Date of slide: 30 June 2016 HepB given only for risk groups or adolescents Not available Not applicable (4 countries or 2%) The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Countries with Influenza vaccine in the national immunization programme Introduced to date (108 countries or 56%) Introduced in parts of the country (1 countries or 1%) Not Available, Not Introduced/No Plans (85 countries or 44%) Not applicable Data source: WHO/IVB Database, as of 30 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Countries and Territories using Yellow fever* vaccine to date * WHO considers that 42 countries/Territories are at risk for Yellow fever Introduced to date Introduced in Hig risk areas (31 countries or 74%) (4 countries or 10%) At risk but not introduced (7 countries or 16%) Not Available / Not at risk Not applicable Data source: WHO/IVB Database, as of 27 June 2016 Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Countries and Territories using JE vaccine to date At risk countries/areas but not introduced (10 countries or 45%) Introduced to date (9 countries or 41%) Introduced in parts of the country (3 countries or 14%) Not applicable Data source: WHO/IVB Database, as of 27 June 2016 International travel Health Database (http://www.who.int/wer/2013/wer8834.pdf?ua=1) Map production Immunization Vaccines and Biologicals (IVB), World Health Organization The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved.